NO20021812D0 - Aromatiske di-ketoderivater, fremgangsmåter for deres produksjon og deres anvendelse som et farmasöytisk middel - Google Patents

Aromatiske di-ketoderivater, fremgangsmåter for deres produksjon og deres anvendelse som et farmasöytisk middel

Info

Publication number
NO20021812D0
NO20021812D0 NO20021812A NO20021812A NO20021812D0 NO 20021812 D0 NO20021812 D0 NO 20021812D0 NO 20021812 A NO20021812 A NO 20021812A NO 20021812 A NO20021812 A NO 20021812A NO 20021812 D0 NO20021812 D0 NO 20021812D0
Authority
NO
Norway
Prior art keywords
pharmaceutical
aromatic
processes
production
keto derivatives
Prior art date
Application number
NO20021812A
Other languages
English (en)
Other versions
NO20021812L (no
Inventor
Laszlo Vertesy
Michael Kurz
Erich Paulus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20021812D0 publication Critical patent/NO20021812D0/no
Publication of NO20021812L publication Critical patent/NO20021812L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20021812A 1999-10-25 2002-04-17 Aromatiske di-ketoderivater, fremgangsmåter for deres produksjon og deres anvendelse som et farmasöytisk middel NO20021812L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99121241 1999-10-25
PCT/EP2000/008103 WO2001030736A2 (en) 1999-10-25 2000-08-19 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors

Publications (2)

Publication Number Publication Date
NO20021812D0 true NO20021812D0 (no) 2002-04-17
NO20021812L NO20021812L (no) 2002-05-14

Family

ID=8239274

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021812A NO20021812L (no) 1999-10-25 2002-04-17 Aromatiske di-ketoderivater, fremgangsmåter for deres produksjon og deres anvendelse som et farmasöytisk middel

Country Status (24)

Country Link
US (1) US6380257B1 (no)
EP (1) EP1248763B1 (no)
JP (1) JP2003512448A (no)
KR (1) KR100755730B1 (no)
CN (1) CN1192999C (no)
AR (1) AR034095A1 (no)
AU (1) AU779352B2 (no)
BR (1) BR0015023A (no)
CA (1) CA2388957C (no)
CZ (1) CZ20021404A3 (no)
EE (1) EE200200216A (no)
HK (1) HK1049827B (no)
HR (1) HRP20020352A2 (no)
HU (1) HUP0203129A3 (no)
IL (1) IL149156A0 (no)
NO (1) NO20021812L (no)
NZ (1) NZ518545A (no)
PL (1) PL205217B1 (no)
RS (1) RS50431B (no)
RU (1) RU2252211C2 (no)
SK (1) SK287428B6 (no)
TR (1) TR200201124T2 (no)
WO (1) WO2001030736A2 (no)
ZA (1) ZA200203034B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208828A1 (de) * 2002-03-01 2003-09-11 Bayer Ag Verfahren zur Reduktion von 3-Heteroaryl-3-oxopropionsäurederivaten
KR101106152B1 (ko) * 2010-05-14 2012-01-20 (주)한국킹유전자 주야 변환형 사인보드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW255880B (no) * 1992-09-09 1995-09-01 Hoechst Ag
TW399041B (en) 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
AU3505497A (en) 1996-07-15 1998-02-09 Mobil Oil Corporation Comonomer pretreated bimetallic catalyst for blow molding and film applications
AR012449A1 (es) * 1997-04-18 2000-10-18 Hoechst Marion Roussell Deutschland Gmbh Kodaistatinas a, b, c y d, proceso para su produccion, y su uso.
DE19740080A1 (de) * 1997-09-12 1999-03-18 Hoechst Marion Roussel De Gmbh Neue Phthalaldehyd-Derivate, Verfahren zu deren Herstellung und deren Verwendung
AU750509B2 (en) * 1998-06-24 2002-07-18 Sanofi-Aventis Deutschland Gmbh Mumbaistatin, a process for its production and its use as a pharmaceutical

Also Published As

Publication number Publication date
RS50431B (sr) 2009-12-31
TR200201124T2 (tr) 2002-09-23
JP2003512448A (ja) 2003-04-02
HRP20020352A2 (en) 2004-02-29
EE200200216A (et) 2003-06-16
NZ518545A (en) 2004-07-30
NO20021812L (no) 2002-05-14
YU27002A (sh) 2005-06-10
SK287428B6 (sk) 2010-09-07
AU7278200A (en) 2001-05-08
KR100755730B1 (ko) 2007-09-06
RU2252211C2 (ru) 2005-05-20
WO2001030736A2 (en) 2001-05-03
PL205217B1 (pl) 2010-03-31
ZA200203034B (en) 2002-11-21
EP1248763A2 (en) 2002-10-16
HK1049827B (zh) 2005-09-02
IL149156A0 (en) 2002-11-10
EP1248763B1 (en) 2014-06-25
HUP0203129A3 (en) 2003-12-29
SK5442002A3 (en) 2002-12-03
AU779352B2 (en) 2005-01-20
HK1049827A1 (en) 2003-05-30
HUP0203129A2 (hu) 2003-01-28
KR20020047262A (ko) 2002-06-21
WO2001030736A3 (en) 2001-11-01
CA2388957A1 (en) 2001-05-03
AR034095A1 (es) 2004-02-04
US6380257B1 (en) 2002-04-30
BR0015023A (pt) 2002-06-18
CZ20021404A3 (cs) 2002-07-17
CN1379752A (zh) 2002-11-13
PL354452A1 (en) 2004-01-12
CN1192999C (zh) 2005-03-16
CA2388957C (en) 2009-01-06

Similar Documents

Publication Publication Date Title
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20025879L (no) Acylfenylureaderivater, fremgangsmåter for fremstilling derav og deres anvendelse som legemiddel
NO20021719D0 (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
DK2298769T3 (da) Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
DK1562946T5 (da) Nye xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel
NO20040680L (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20006251D0 (no) Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20021689D0 (no) 5-rings heterosykliske derivater, fremstilling derav og anvendelse som medikamenter
NO20014702L (no) Diarylderivater og deres anvendelse som medikamenter
NO20030494D0 (no) Nye heterosykliske forbindelser, deres fremstilling og deres anvendelse sommedikamenter, s¶rlig som antibakterielle midler
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DK1445252T3 (da) Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
NO20025029D0 (no) Nye epotilonderivater, fremgangsmåte for fremstilling derav og deres farmasöytiske anvendelse
NO20013900D0 (no) Epotilonderivater, fremgangsmate og anvendelse derav som legemiddel
NO20043349L (no) Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
DK1523473T3 (da) Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel.
DK1200444T3 (da) Nye xanthon-forbindelser, deres fremstilling og anvendelse som lægemiddel
DK1261603T3 (da) Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
ERR Erratum

Free format text: I PATENTTIDENDE NR. 13/06 BLE PATENTSOKNAD NR. 20021812 FEILAKTIG KUNNGJORT ENDELIG HENLAGT. SOKNADEN ER UNDER BEHANDLING.

FC2A Withdrawal, rejection or dismissal of laid open patent application